Search

Your search keyword '"Strauss, H. -G."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Strauss, H. -G." Remove constraint Author: "Strauss, H. -G."
49 results on '"Strauss, H. -G."'

Search Results

2. 1524P Epidemiology and demography of gynecological sarcoma: Results of the prospective intergroup registry for gynecological sarcoma REGSA (NOGGO RU1)

3. 604P T cell density and immune phenotypes at the invasive margin correlate with prognosis in epithelial vulvar cancer

5. Uptake of hysterectomy and bilateral salpingooophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

6. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

8. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study

9. Outcome parameters in node-negative vulvar cancer - a subset analysis of the AGO CaRE-1 study: ID 329

10. Importance of pelvic Lymphonodectomy in Squamous Cell Carcinoma of the Vulva (VSCC) Subgroup Analysis of the AGO-CaRE-1 Study

11. The influence of age on treatment and prognosis of patients with squamous cell vulvar cancer (VSCC)- a subset analysis of the AGO-CaRE-1 study

12. Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database

13. DEGRO 2004: 10. Jahreskongress der Deutschen Gesellschaft für Radioonkologie

14. Bedeutung der pelvinen Lymphonodektomie beim Plattenepithelkarzinom der Vulva (VSCC) – Subgruppenanalyse der AGO-CaRE-1 Studie

15. P193 p53 and p16 expression profiles identify three prognostically subgroups in vulvar cancer : a TMA based study by the AGO-CaRE-translational study group : Poster exhibition Day 2

17. P193 p53 and p16 expression profiles identify three prognostically subgroups in vulvar cancer: a TMA based study by the AGO-CaRE-translational study group

20. Outcome parameters in node-negative vulvar cancer - subset analysis of the AGO CaRE-1 study

21. AGO Vulva CaRE-1 multicenter study - adjuvant radio(chemo)therapy in vulvar cancer

22. Prognostic impact of the time interval between primary and re-staging surgery in patients with borderline ovarian tumours (BOT) : An analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group

23. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)

24. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)

25. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

26. Outcome parameters in node-negative vulvar cancer - subset analysis of the AGO CaRE-1 study

30. Autorenverzeichnis

35. DEGRO 2004

40. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants:a Prospective Lynch Syndrome Database report

41. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

43. Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer.

44. [Not Available].

45. Ectopic lobular breast cancer of the vulva.

46. Significance of endovaginal ultrasonography in assessing tamoxifen-associated changes of the endometrium. A prospective study.

47. [Preoperative axilla sonography in breast tumor suspected of malignancy--a diagnostic advantage?].

48. [Recurrent vulvar carcinoma at the Halle/S. University Gynecologic Clinic 1971-1990--diagnosis and results of therapy].

49. [HELLP syndrome on the 6th puerperal day. Presentation of case reports].

Catalog

Books, media, physical & digital resources